Harvard Radiation Oncology Program, Brigham and Women’s Hospital, Department of Radiation Oncology, Boston, MA 02115, USA.
Int J Radiat Oncol Biol Phys. 2012 Mar 1;82(3):e463-7. doi: 10.1016/j.ijrobp.2011.07.003. Epub 2011 Sep 21.
It has been recently shown that diabetes mellitus (DM) is significantly associated with the likelihood of presenting with high-grade prostate cancer (PCa) or Gleason score (GS) 8 to 10; however, whether this association holds for both Type 1 and 2 DM is unknown. In this study we evaluated whether DM Type 1, 2, or both are associated with high-grade PCa after adjusting for known predictors of high-grade disease.
Between 1991 and 2010, a total of 15,330 men diagnosed with PCa and treated with radiation therapy were analyzed. A polychotomous logistic regression analysis was performed to evaluate whether Type 1 or 2 DM was associated with odds of GS 7 or GS 8 to 10 compared with 6 or lower PCa, adjusting for African American race, age, prostate-specific antigen (PSA) level, and digital rectal examination findings.
Men with Type 1 DM (adjusted odds ratio [AOR], 2.05; 95% confidence interval [CI], 1.28-3.27; p = 0.003) or Type 2 DM (AOR, 1.58; 95% CI, 1.26-1.99; p < 0.001) were significantly more likely to be diagnosed with GS 8 to 10 PCa compared with nondiabetic men. However this was not true for GS 7, for which these respective results were AOR, 1.30; 95% CI, 0.93-1.82; p = 0.12 and AOR, 1.13; 95% CI, 0.98-1.32; p = 0.10.
Type 1 and 2 DM were associated with a higher odds of being diagnosed with Gleason score 8 to 10 but not 7 PCa. Pending validation, men who are diagnosed with Type I DM with GS 7 or lower should be considered for additional workup to rule out occult high-grade disease.
最近有研究表明,糖尿病(DM)与发生高级别前列腺癌(PCa)或 Gleason 评分 8-10 的可能性显著相关;然而,这种相关性是否适用于 1 型和 2 型糖尿病尚不清楚。在这项研究中,我们评估了在调整已知高级别疾病预测因素后,1 型、2 型或两者是否与高级别 PCa 相关。
1991 年至 2010 年间,共分析了 15330 名诊断为 PCa 并接受放疗的男性患者。采用多项逻辑回归分析评估 1 型或 2 型 DM 是否与与 GS 6 或更低相比,GS 7 或 GS 8-10 的几率相关,调整了非裔美国人种族、年龄、前列腺特异性抗原(PSA)水平和直肠指检结果。
患有 1 型糖尿病(调整后的优势比 [AOR],2.05;95%置信区间 [CI],1.28-3.27;p=0.003)或 2 型糖尿病(AOR,1.58;95%CI,1.26-1.99;p<0.001)的男性更有可能被诊断为 GS 8-10 PCa,而非糖尿病男性。然而,对于 GS 7,这些结果分别为 AOR,1.30;95%CI,0.93-1.82;p=0.12 和 AOR,1.13;95%CI,0.98-1.32;p=0.10,情况并非如此。
1 型和 2 型糖尿病与被诊断为 Gleason 评分 8-10 的几率增加相关,但与 Gleason 评分 7 无关。在等待验证的情况下,被诊断为 1 型糖尿病且 GS 为 7 或更低的男性应考虑进行额外检查以排除隐匿性高级别疾病。